INNOVATIVE HEALTHCARE supplier risk profile Q1 2026: 52 shipments, 12 suppliers, Singapore-focused sourcing.
INNOVATIVE HEALTHCARE processed 52 shipments across 12 suppliers in Q1 2026, drawing primarily from Singapore (52% of volume). The importer sourced from five countries across five HS codes, with rubber products (HS 40) dominating at 44% of shipments. HARTALEGA NGC emerged as the dominant supplier with 33 shipments across multiple facilities in Singapore, Malaysia, South Korea, and China.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
INNOVATIVE HEALTHCARE registered zero sanctions watchlist matches in Q1 2026. No suppliers in the sourcing network showed UFLPA forced-labor exposure flagging.
12 distinct tier-1 suppliers in Q1 2026
| HARTALEGA NGC | Singapore | 23 |
| HARTALEGA NGC | Malaysia | 5 |
| ECO WIPES VIETNAM | Vietnam | 3 |
| PREMIER MEDICAL GLOVES FACTORY | South Korea | 3 |
| HARTALEGA NGC | South Korea | 3 |
| HARTALEGA NGC | China | 2 |
| MAH SING HEALTHCARE | Singapore | 2 |
| TEKMEDIC M | Singapore | 1 |
Share of Q1 2026 inbound shipments by source country
10 tier-2 + 4 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.